Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife. [electronic resource]
Producer: 20020219Description: 936-8 p. digitalISSN:- 0340-6245
No physical items for this record
Publication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.